Relmada Therapeutics, Inc. (RLMD)

7.25 +0.19 (+2.69%) USD  |  NASDAQ  |  Apr 23, 16:00
7.45 +0.20 (+2.76%) After-Hours: 20:00
More

Relmada Therapeutics Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade